Journal of Pharmaceutical Investigation

  • 제40권6호
  • /
  • Pages.339-345
  • /
  • 2010
  • /
  • 2093-5552(pISSN)
  • /
  • 2093-6214(eISSN)
한국약제학회 (The Korean Society of Pharmaceutical Sciences and Technology)
권호 표지
DOI QR코드

DOI QR Code

Preparation and Evaluation of Novel Fenofibrate-loaded Self-Microemulsifying Drug Delivery System (SMEDDS)

  • 투고 : 2010.07.26
  • 심사 : 2010.10.20
  • 발행 : 2010.12.20
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Fenofibrate has been used for many years to lower cholesterol levels and its pharmacokinetic profile is well understood. However, due to its low solubility in water, it has low bioavailability after oral administration. In order to improve the dissolution rate, fenofibrate was formulated into a self-microemulsifying drug delivery systems (SMEDDS). We used pseudo-ternary phase diagrams to evaluate the area of microemulsification, and an in vitro dissolution test was used to investigate the dissolution rate of fenofibrate. The optimized formulation for in vitro dissolution assessment consisted of Lauroglycol FCC (60%), Solutol HS 15 (27%), and Transcutol-P (13%). The mean droplet size of the oil phase in the microemulsion formed from the SMEDDS was about 130 nm. The dissolution rate of fenofibrate from SMEDDS was significantly higher than that of the reference tablet. Our studies suggested that the fenofibrate containing SMEDDS composition can effectively increase the solubility and oral bioavailability of poorly water-soluble drugs.

키워드

참고문헌

  1. Kang, B.K., Lee, J.S., C, S.K., Jeong, S.Y., Yuk, S.H., Khang., G.S., Lee, H.B., Cho, S.H., 2004. Development of selfmicroemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm. 274, 65-73. https://doi.org/10.1016/j.ijpharm.2003.12.028
  2. Charman, SA., Charman, WN., Rogge, MC., Wilson, TD., Dutko, FJ., Pouton, CW., 1992. Self-emulsifying drug delivery systems: Formulation and biopharmaceutic evaluation of an investigational lipophilic compound. Pharm Res. 9, 87-93. https://doi.org/10.1023/A:1018987928936
  3. Constantinides, PP., 1995. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm Res. 12, 1561-1572. https://doi.org/10.1023/A:1016268311867
  4. Curtet, B., Teillaud, E., Reginault, P., inventors., 1980. Fournier Innovation et Synergie, assignee. Novel dosage form of fenofibrate. US patent 4895726. January 23.
  5. Danielsson, I., Lindman, B., 1981. The definition of a microemulsion, Colloids and Surfaces. 3, 391-392. https://doi.org/10.1016/0166-6622(81)80064-9
  6. Georgakopoulos, E., Farah, N., Vergnault, G., 1992-93. Oral anhydrous nonionic microemulsions administrated in softgel capsules. Gattefosse, B.T., 85, 11-20.
  7. Gershanik, T., Benzeno, S., Benita, S., 1998. Interaction of a self-emulsifying lipid drug delivery system with the everted rat intestinal mucosa as a function of droplet size and surface charge. Pharm Res. 15, 863-869. https://doi.org/10.1023/A:1011968313933
  8. Groves, M.J., de Galindez, D.A., 1976. The self-emulsifying action of mixed surfactants in oil. Acta. Pharm. Suec. 13, 361-372.
  9. Hanafy, A., Spahn-Langguth, H., Vergnault, G., Grenier, P., Tubic Grozdanis, M., Lenhardt, T., Langguth, P., 2007. Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug. Adv. Drug Deliv. Rev. 59, 419-426. https://doi.org/10.1016/j.addr.2007.04.005
  10. Kim., H.J., Yoon., K.A., Hahn, M.K., Park, E.S., Chi, S.C., 2000. Preparation and in vitro evaluation of self-microemulsifying drug delivery systems containing idebenone. Drug Dev Ind Pharm. 26, 523-529. https://doi.org/10.1081/DDC-100101263
  11. Kasim, N.A., Whitehouse, M., Ramachandran, C., Bermejo, M., Lennernas, H., Hussain, A.S., Junginger, H.E., Stavchansky, S.A., Midha, K.K., Shah, V.P., Amidon, G.L., 2004. Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Mol Pharm. 1, 85-96. https://doi.org/10.1021/mp034006h
  12. Kawakami, K., Yoshikawa, T., Moroto, Y., Kanaoka, E., Takahashi, K., Nishihara, Y., Masuda, K., 2002. Microemulsion Formulation for enhanced absorption of poorly soluble drugs I. Prescription design. J. Control. Release. 81, 65-74. https://doi.org/10.1016/S0168-3659(02)00049-4
  13. Keck, C.M., Muller, R.H, 2006. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenization. Eur. J. Pharm. Bio. 62, 3-16 https://doi.org/10.1016/j.ejpb.2005.05.009
  14. Kim., K.H., Rhee., Y.S., Bae, J.H., Chi, S.C., Park, E.S., 1999. Improvement of Dissolution Rate of Poorly Water Soluble Drug Using Self-microemulsifying Drug Delivery System. J. Kor. Pharm. Sci. 29, 37-45.
  15. Kreuter, J. (Ed.), 1994. Colloidal Drug Delivery Systems. Marcel Dekker, New York, 31-65.
  16. Law, D., Wang, W., Schmitt, E., Qiu, Y., Krill, S.K., Fort, J.J., 2003. Properties of rapidly dissolving eutectic mixtures of poly(ethylene glycol) and fenofibrate: the eutectic microstructure. J. Pharm. Sci. 92, 505-515. https://doi.org/10.1002/jps.10324
  17. Mayer, D., 1988. Surfactant Science and Technology. VCH Publishers, Inc., 174-175.
  18. Najib, J., 2002. Fenofibrate in the treatment of dyslipidemia: a review of the data as they relate to the new suprabioavailable tablet Formulation. Clin Ther. 24, 2022-2050. https://doi.org/10.1016/S0149-2918(02)80095-9
  19. Patel, A.R., Vavia, P.R., 2006. Effect of hydrophilic polymer on solubilization of fenofibrate by cyclodextrin complexation. J. Incl. Phenom. Macrocycl. Chem. 56, 247-251. https://doi.org/10.1007/s10847-006-9091-4
  20. Physician’s Desk Reference 2000. 54th ed. Montvale, NJ:Medical Economics Company, 476-477.
  21. Pouton, C.W., 2000. Lipid Formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ‘self-microemulsifying’ drug delivery systems. Eur. J. Pharm. Sci. 11, S93-S98. https://doi.org/10.1016/S0928-0987(00)00167-6
  22. Sarciaux, J.M., Acar, L., Sado, P.A., 1995. Using microemulsion Formulations for drug delivery of therapeutic peptides. Int. J. Pharm. 120, 127-136. https://doi.org/10.1016/0378-5173(94)00386-J
  23. Schulman, J.H., Montagne, J.B., 1961. Formation of microemulsions by amino alkyl alcohols. Ann. N. Y. Acad. Sci. 92, 366-371. https://doi.org/10.1111/j.1749-6632.1961.tb44987.x
  24. Schulman, J.H., Stoekenius, W., Prince, L., M. J., 1959. Mechanism of formation and structure of microemulsions by electron microscopy. Phys. Chem., 63, 1677-1678. https://doi.org/10.1021/j150580a027
  25. Shah, N.H., Carvajal, M.T., Patel, C.I., Infeld, M.H., Malick, A.W., 1994. Selfemulsifying drug delivery systems (SEDDS) with polyglycolysed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int J Pharm. 106, 15-23. https://doi.org/10.1016/0378-5173(94)90271-2
  26. Torrado, S., L’opez, M.L., Torrado, G., Bol’as, F., Torrado, S., Cad’orniga, R., 1997. A novel Formulation of albendazole solution: oral bioavailability and efficacy evaluation. Int. J. Pharm., 156, 181-187. https://doi.org/10.1016/S0378-5173(97)00204-4
  27. Vogt, M., Kunath, K., Dressman, J.B., 2008. Dissolution enhacement of fenofibrate by microniziation, cogrinding and proaydrying: Comparison with commercial preparations. Eur. J. Pharm. Biopharm. 68, 283-288. https://doi.org/10.1016/j.ejpb.2007.05.010

피인용 문헌

  1. Development of stabilized tenofovir disoproxil tablet: degradation profile, stabilization, and bioequivalence in beagle dogs vol.44, pp.5, 2018, https://doi.org/10.1080/03639045.2017.1411943